Professional
Added to YB: 2025-06-09
Pitch date: 2025-03-31
RPRX [neutral]
Royalty Pharma plc
+76.21%
current return
Author Info
No bio for this author
Company Info
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
Market Cap
$20.5B
Pitch Price
$30.39
Price Target
N/A
Dividend
1.96%
EV/EBITDA
20.15
P/E
26.89
EV/Sales
13.49
Sector
Pharmaceuticals
Category
special_situation
PM Capital Global Companies Fund Portfolio Holding: Royalty Pharma plc
RPRX (holding update): +20% on consolidating split corporate structure into one entity. $18B pharma buys royalty streams on other companies' meds instead of developing own. Will now look more like peers, driving multiple expansion. Mid-to-high single digit earnings growth expected with dividend and opportunistic buybacks.
Read full article (1 min)